Dr Michael Turner
BA(Hons) BMBCh MRCP(UK) MSc
Michael began his DPhil in October 2020 and is studying the genetic determinants of blood pressure in the Mexico City Prospective Study. The work aims to discover new blood pressure-determining variants and validate the findings made in other populations. He hopes to go on to study the associations of genetically-predicted blood pressure with important causes of death.
Michael has previously completed a BA(Hons) and BMBCh from the University of Oxford before working as a doctor in Manchester and the Thames Valley deanery. He undertook the Oxford MSc in Global Health Science during which he studied the association between UMOD variants and progression of chronic kidney disease. He subsequently went on to Renal and General Medicine specialist training – he has taken time out of this to undertake his DPhil.
UMOD-ulating CKD risk: untangling the relationship between urinary uromodulin, blood pressure, and kidney disease
Turner M. and Staplin N., (2021), Kidney International, 100, 1168 - 1170
Candida crescents in a renal allograft.
Turner MP. et al, (2020), Kidney Int, 98
Heavy chain deposition disease presenting with raised anti-GBM antibody levels; a case report.
Turner M. et al, (2020), BMC Nephrol, 21
Acute colonic pseudo-obstruction associated with abdominal paracentesis.
Turner MP. et al, (2017), BMJ Case Rep, 2017
Designing a better appraisal system that meets the needs of trainees and the public.
Turner MP., (2015), BMJ, 351